The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

A research team at the Max Planck Institute for Chemical Ecology has successfully combined single-cell RNA sequencing ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for certain skin and lung cancers.

Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq Library Prep Kit ...

Plasmidsaurus, the leading global Sequencing as a Service company, today announced the launch of its new RNA-Seq service. Applying Plasmidsaurus's innovative approach to sequencing as a service to ...

Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...

New research in Sweden has produced a "blueprint" revealing how the human heart is built during prenatal development. It ...

Avidity Biosciences ( ($RNA) ) has issued an announcement. On October 25, 2025, Avidity Biosciences announced a merger agreement with Novartis AG, ...

Novartis acquires Avidity Biosciences for $12B to boost growth and rare disease pipeline. Explore impacts, risks, and outlook ...

New research in Sweden has produced a "blueprint" revealing how the human heart is built during prenatal development.

The company says the system can benefit pharmaceutical and biotech firms seeking rapid feedback on drug candidates or genome editing.

The United States lipid nanoparticle market is projected to expand from $210.34 billion in 2024 to $519.18 billion by 2033, ...